Combination of | |
---|---|
Ipratropium bromide | Muscarinic antagonist |
Salbutamol | Short-acting β2-adrenergic agonist |
Clinical data | |
Trade names | Combivent, Duoneb, Breva, others |
AHFS/Drugs.com | Professional Drug Facts |
MedlinePlus | a601063 |
License data | |
Routes of administration | Inhalation |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
(verify) |
Ipratropium bromide/salbutamol, sold under the brand name Combivent among others, is a combination medication used to treat chronic obstructive pulmonary disease (COPD).[1][4][5] It contains ipratropium (an anticholinergic) and salbutamol (albuterol, a β2-adrenergic agonist).[1]
Common side effects include sore throat, muscle cramps, and nausea.[1] Other side effects may include bronchospasm, allergic reactions, and upper respiratory tract infections.[1] Safety in pregnancy is unclear.[6][1]
The combination was approved for medical use in the United States in 1996.[7] It is available as a generic medication.[4] In 2022, it was the 178th most commonly prescribed medication in the United States, with more than 2 million prescriptions.[8][9]